| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fusion Proteins, bcr-abl | 60 | 2014 | 430 | 5.960 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 38 | 2021 | 494 | 5.820 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 44 | 2021 | 686 | 4.350 |
Why?
|
| Leukemia, Myeloid, Acute | 74 | 2022 | 3626 | 3.730 |
Why?
|
| Staurosporine | 24 | 2020 | 241 | 3.080 |
Why?
|
| Pyrimidines | 50 | 2016 | 3044 | 2.980 |
Why?
|
| Protein Kinase Inhibitors | 39 | 2020 | 5693 | 2.750 |
Why?
|
| Leukemia, Myeloid | 37 | 2020 | 693 | 2.630 |
Why?
|
| Colony-Stimulating Factors | 49 | 1990 | 218 | 2.580 |
Why?
|
| Protein-Tyrosine Kinases | 62 | 2014 | 2428 | 2.570 |
Why?
|
| Piperazines | 41 | 2016 | 2548 | 2.260 |
Why?
|
| Proto-Oncogene Proteins | 54 | 2018 | 4522 | 2.150 |
Why?
|
| Hematopoietic Stem Cells | 66 | 2024 | 3408 | 1.990 |
Why?
|
| Antineoplastic Agents | 51 | 2022 | 13650 | 1.750 |
Why?
|
| Interleukin-3 | 35 | 2005 | 425 | 1.710 |
Why?
|
| Leukemia | 21 | 2016 | 1518 | 1.650 |
Why?
|
| Drug Resistance, Neoplasm | 32 | 2019 | 5332 | 1.440 |
Why?
|
| Cell Transformation, Neoplastic | 35 | 2011 | 2843 | 1.360 |
Why?
|
| Growth Substances | 31 | 2002 | 759 | 1.330 |
Why?
|
| Point Mutation | 13 | 2014 | 1591 | 1.240 |
Why?
|
| Thiazoles | 8 | 2013 | 1530 | 1.240 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 46 | 1999 | 892 | 1.230 |
Why?
|
| Mutant Proteins | 6 | 2019 | 487 | 1.220 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 12 | 2020 | 120 | 1.200 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 16 | 2013 | 1621 | 1.180 |
Why?
|
| Tyrosine | 32 | 2011 | 1425 | 1.140 |
Why?
|
| Signal Transduction | 77 | 2020 | 23621 | 1.140 |
Why?
|
| Nuclear Proteins | 24 | 2015 | 5794 | 1.060 |
Why?
|
| Enzyme Inhibitors | 24 | 2016 | 3726 | 1.050 |
Why?
|
| Transcription Factors | 24 | 2024 | 12158 | 1.030 |
Why?
|
| Hematologic Neoplasms | 6 | 2022 | 1907 | 1.010 |
Why?
|
| Benzamides | 36 | 2013 | 1376 | 0.970 |
Why?
|
| Mutation | 46 | 2021 | 30211 | 0.970 |
Why?
|
| Phosphorylation | 71 | 2021 | 8310 | 0.920 |
Why?
|
| Genes, abl | 11 | 2006 | 69 | 0.900 |
Why?
|
| Adaptor Proteins, Signal Transducing | 16 | 2002 | 2902 | 0.890 |
Why?
|
| Trans-Activators | 21 | 2021 | 2856 | 0.880 |
Why?
|
| Janus Kinase 2 | 19 | 2021 | 561 | 0.880 |
Why?
|
| Hematopoiesis | 27 | 2024 | 2056 | 0.840 |
Why?
|
| Cell Line | 89 | 2014 | 15567 | 0.820 |
Why?
|
| Cell Line, Tumor | 42 | 2024 | 17097 | 0.810 |
Why?
|
| Milk Proteins | 6 | 2005 | 161 | 0.800 |
Why?
|
| Tumor Cells, Cultured | 51 | 2021 | 6106 | 0.780 |
Why?
|
| Phosphoproteins | 21 | 2003 | 2448 | 0.780 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 11 | 1999 | 115 | 0.770 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 6 | 2012 | 367 | 0.760 |
Why?
|
| Receptor, Notch2 | 3 | 2014 | 90 | 0.760 |
Why?
|
| Granulocytes | 28 | 2018 | 551 | 0.760 |
Why?
|
| Bone Marrow Cells | 34 | 2013 | 2412 | 0.750 |
Why?
|
| Leukemia, Experimental | 8 | 2016 | 224 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-kit | 12 | 2019 | 723 | 0.730 |
Why?
|
| Cell Cycle | 29 | 2014 | 2927 | 0.720 |
Why?
|
| Proto-Oncogene Proteins c-abl | 7 | 2010 | 145 | 0.710 |
Why?
|
| Cell Division | 51 | 2005 | 4473 | 0.700 |
Why?
|
| Alternative Splicing | 4 | 2014 | 1103 | 0.700 |
Why?
|
| Mice | 118 | 2024 | 81912 | 0.700 |
Why?
|
| Animals | 167 | 2024 | 168965 | 0.680 |
Why?
|
| Hematopoietic Cell Growth Factors | 9 | 1999 | 98 | 0.670 |
Why?
|
| Therapies, Investigational | 1 | 2020 | 110 | 0.650 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2020 | 456 | 0.650 |
Why?
|
| Drug Repositioning | 2 | 2022 | 246 | 0.640 |
Why?
|
| Small Molecule Libraries | 4 | 2021 | 742 | 0.620 |
Why?
|
| Ubiquitin-Protein Ligases | 9 | 2002 | 1900 | 0.620 |
Why?
|
| Monocytes | 28 | 1992 | 2598 | 0.610 |
Why?
|
| Antiviral Agents | 3 | 2022 | 3070 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2022 | 8628 | 0.580 |
Why?
|
| Phosphatidylinositol 3-Kinases | 16 | 2024 | 2883 | 0.580 |
Why?
|
| Drug Synergism | 12 | 2020 | 1759 | 0.570 |
Why?
|
| Cytoskeletal Proteins | 12 | 2003 | 1326 | 0.560 |
Why?
|
| Stromal Cells | 8 | 2013 | 1335 | 0.550 |
Why?
|
| Cell Proliferation | 27 | 2021 | 10455 | 0.550 |
Why?
|
| Histones | 2 | 2022 | 2597 | 0.530 |
Why?
|
| Receptors, Cell Surface | 14 | 2003 | 2815 | 0.520 |
Why?
|
| Antigens, Surface | 31 | 1991 | 1617 | 0.510 |
Why?
|
| DNA-Binding Proteins | 19 | 2018 | 9612 | 0.510 |
Why?
|
| src Homology Domains | 9 | 2003 | 360 | 0.500 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2021 | 1608 | 0.500 |
Why?
|
| Cell Lineage | 2 | 2024 | 2575 | 0.500 |
Why?
|
| Apoptosis | 32 | 2024 | 9513 | 0.500 |
Why?
|
| Humans | 342 | 2024 | 767040 | 0.490 |
Why?
|
| Isoquinolines | 3 | 2016 | 349 | 0.480 |
Why?
|
| Recombinant Fusion Proteins | 18 | 2007 | 3738 | 0.480 |
Why?
|
| Transfection | 33 | 2005 | 5753 | 0.470 |
Why?
|
| Phosphotyrosine | 15 | 2009 | 458 | 0.470 |
Why?
|
| Benzothiazoles | 5 | 2020 | 244 | 0.460 |
Why?
|
| Receptors, Notch | 10 | 2009 | 751 | 0.460 |
Why?
|
| Cell Cycle Proteins | 6 | 2014 | 3440 | 0.460 |
Why?
|
| Genes, ras | 2 | 2014 | 656 | 0.460 |
Why?
|
| Xenograft Model Antitumor Assays | 14 | 2021 | 3608 | 0.450 |
Why?
|
| Up-Regulation | 8 | 2021 | 4143 | 0.450 |
Why?
|
| Drug Screening Assays, Antitumor | 9 | 2019 | 719 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 361 | 0.450 |
Why?
|
| Tetradecanoylphorbol Acetate | 15 | 1992 | 826 | 0.440 |
Why?
|
| Bone Marrow | 43 | 2004 | 2926 | 0.440 |
Why?
|
| Membrane Proteins | 14 | 2015 | 7868 | 0.440 |
Why?
|
| Cell Differentiation | 32 | 2024 | 11657 | 0.440 |
Why?
|
| Cell Survival | 21 | 2017 | 5750 | 0.430 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 12 | 2021 | 11872 | 0.430 |
Why?
|
| Protein Tyrosine Phosphatases | 10 | 2001 | 457 | 0.430 |
Why?
|
| Enzyme Activation | 25 | 2013 | 3587 | 0.430 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 | 2006 | 1559 | 0.430 |
Why?
|
| STAT5 Transcription Factor | 13 | 2012 | 268 | 0.410 |
Why?
|
| Cell Movement | 14 | 2010 | 5203 | 0.410 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3112 | 0.410 |
Why?
|
| Cyclins | 7 | 2006 | 605 | 0.410 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3234 | 0.400 |
Why?
|
| RNA Precursors | 1 | 2013 | 196 | 0.400 |
Why?
|
| Protein Kinases | 11 | 2008 | 1610 | 0.400 |
Why?
|
| Oncogenes | 9 | 2013 | 1232 | 0.400 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2010 | 200 | 0.400 |
Why?
|
| RNA, Messenger | 30 | 2015 | 12793 | 0.400 |
Why?
|
| Neoplasm Proteins | 11 | 2016 | 3599 | 0.400 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 384 | 0.390 |
Why?
|
| Receptor, Notch1 | 4 | 2018 | 518 | 0.390 |
Why?
|
| Protein Structure, Tertiary | 17 | 2012 | 3760 | 0.390 |
Why?
|
| Phenylurea Compounds | 4 | 2020 | 531 | 0.380 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 525 | 0.380 |
Why?
|
| Protein Kinase C | 5 | 2008 | 1206 | 0.380 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 4 | 1997 | 434 | 0.370 |
Why?
|
| Mutation, Missense | 6 | 2010 | 2592 | 0.370 |
Why?
|
| Cell Line, Transformed | 12 | 2003 | 861 | 0.370 |
Why?
|
| Amino Acid Substitution | 7 | 2010 | 1743 | 0.370 |
Why?
|
| Myeloproliferative Disorders | 8 | 2021 | 616 | 0.360 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 2952 | 0.360 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2014 | 1761 | 0.350 |
Why?
|
| Stem Cell Factor | 10 | 1999 | 194 | 0.350 |
Why?
|
| Mice, Nude | 12 | 2016 | 3618 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2016 | 2457 | 0.350 |
Why?
|
| Insect Proteins | 2 | 2002 | 253 | 0.350 |
Why?
|
| Carcinoma, Mucoepidermoid | 3 | 2021 | 91 | 0.350 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 99 | 0.330 |
Why?
|
| Recombinant Proteins | 32 | 2005 | 6507 | 0.330 |
Why?
|
| Cytarabine | 10 | 2000 | 695 | 0.330 |
Why?
|
| Receptors, Erythropoietin | 4 | 2008 | 144 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2024 | 1405 | 0.320 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1989 | 0.320 |
Why?
|
| src-Family Kinases | 3 | 2010 | 539 | 0.320 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 11 | 1994 | 631 | 0.320 |
Why?
|
| RNA Splicing | 1 | 2013 | 903 | 0.320 |
Why?
|
| Carbanilides | 1 | 2008 | 18 | 0.320 |
Why?
|
| Phosphoric Monoester Hydrolases | 3 | 2000 | 414 | 0.320 |
Why?
|
| Drug Design | 4 | 2013 | 1045 | 0.310 |
Why?
|
| Leukemia, Lymphoid | 13 | 2005 | 307 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 12 | 2002 | 1612 | 0.310 |
Why?
|
| Benzimidazoles | 3 | 2020 | 862 | 0.310 |
Why?
|
| Multiple Myeloma | 7 | 2022 | 5186 | 0.310 |
Why?
|
| B-Lymphocytes | 18 | 2014 | 4787 | 0.300 |
Why?
|
| Biological Products | 1 | 2017 | 948 | 0.300 |
Why?
|
| Cell Adhesion | 15 | 2011 | 3093 | 0.300 |
Why?
|
| Gene Expression Regulation, Leukemic | 5 | 2014 | 658 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 22 | 2017 | 10748 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 12 | 1997 | 1349 | 0.300 |
Why?
|
| Transcriptional Activation | 6 | 2014 | 1751 | 0.290 |
Why?
|
| Carrier Proteins | 8 | 2007 | 4925 | 0.290 |
Why?
|
| Thrombocythemia, Essential | 2 | 2006 | 114 | 0.290 |
Why?
|
| Thrombopoietin | 4 | 1999 | 225 | 0.290 |
Why?
|
| Cell Physiological Phenomena | 1 | 2008 | 149 | 0.280 |
Why?
|
| Polycythemia Vera | 2 | 2006 | 160 | 0.280 |
Why?
|
| Molecular Sequence Data | 27 | 2010 | 17608 | 0.280 |
Why?
|
| Reactive Oxygen Species | 7 | 2010 | 2144 | 0.280 |
Why?
|
| Precipitin Tests | 15 | 2004 | 816 | 0.280 |
Why?
|
| G1 Phase | 7 | 2006 | 403 | 0.280 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 729 | 0.270 |
Why?
|
| Mutagenesis | 3 | 2009 | 1227 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2021 | 5716 | 0.270 |
Why?
|
| Erythropoietin | 6 | 2008 | 718 | 0.260 |
Why?
|
| Receptors, Immunologic | 9 | 1995 | 1418 | 0.260 |
Why?
|
| Lymphoid Tissue | 2 | 2007 | 445 | 0.260 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 167 | 0.260 |
Why?
|
| Aniline Compounds | 3 | 2021 | 1080 | 0.250 |
Why?
|
| Interferon-gamma | 14 | 1996 | 3154 | 0.250 |
Why?
|
| Proto-Oncogenes | 6 | 2003 | 321 | 0.250 |
Why?
|
| Biomimetic Materials | 1 | 2007 | 170 | 0.250 |
Why?
|
| Transcription, Genetic | 18 | 2010 | 7611 | 0.250 |
Why?
|
| Cytokines | 12 | 2016 | 7446 | 0.250 |
Why?
|
| Pyrazines | 3 | 2021 | 1204 | 0.250 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2016 | 252 | 0.250 |
Why?
|
| DNA Mutational Analysis | 9 | 2010 | 4114 | 0.240 |
Why?
|
| T-Lymphocytes | 19 | 2007 | 10254 | 0.240 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 1996 | 301 | 0.240 |
Why?
|
| Proteins | 12 | 2002 | 6001 | 0.240 |
Why?
|
| Cadherins | 1 | 2009 | 903 | 0.240 |
Why?
|
| Cells, Cultured | 33 | 2020 | 18989 | 0.240 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3232 | 0.240 |
Why?
|
| Amino Acid Sequence | 19 | 2016 | 13411 | 0.240 |
Why?
|
| Down-Regulation | 10 | 2011 | 2931 | 0.230 |
Why?
|
| Interleukin-1 | 7 | 1992 | 1252 | 0.230 |
Why?
|
| Pyrimidinones | 3 | 2021 | 385 | 0.230 |
Why?
|
| CDC2 Protein Kinase | 3 | 2018 | 212 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 44 | 1997 | 9245 | 0.230 |
Why?
|
| Blast Crisis | 3 | 2004 | 102 | 0.220 |
Why?
|
| Structure-Activity Relationship | 13 | 2017 | 3052 | 0.220 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2015 | 464 | 0.220 |
Why?
|
| Megakaryocytes | 8 | 2000 | 557 | 0.220 |
Why?
|
| Immunoblotting | 9 | 2010 | 1647 | 0.220 |
Why?
|
| Lymphoma | 5 | 2016 | 1896 | 0.220 |
Why?
|
| Pandemics | 2 | 2020 | 8736 | 0.220 |
Why?
|
| Genes | 7 | 2004 | 1824 | 0.210 |
Why?
|
| Tandem Repeat Sequences | 1 | 2004 | 183 | 0.210 |
Why?
|
| Philadelphia Chromosome | 6 | 2001 | 119 | 0.210 |
Why?
|
| Protease Inhibitors | 3 | 2020 | 750 | 0.210 |
Why?
|
| GATA1 Transcription Factor | 1 | 2024 | 306 | 0.210 |
Why?
|
| Models, Biological | 13 | 2011 | 9464 | 0.210 |
Why?
|
| Janus Kinases | 3 | 2013 | 253 | 0.210 |
Why?
|
| Antigens, Differentiation | 8 | 1994 | 920 | 0.210 |
Why?
|
| Base Sequence | 18 | 2014 | 12414 | 0.210 |
Why?
|
| Drosophila Proteins | 3 | 2003 | 1705 | 0.210 |
Why?
|
| Kinetics | 19 | 1999 | 6287 | 0.210 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2004 | 777 | 0.200 |
Why?
|
| Pyrazoles | 4 | 2021 | 2028 | 0.200 |
Why?
|
| Molecular Structure | 5 | 2017 | 1882 | 0.200 |
Why?
|
| Quinolines | 1 | 2008 | 770 | 0.200 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2002 | 74 | 0.200 |
Why?
|
| Blotting, Northern | 13 | 2003 | 1550 | 0.200 |
Why?
|
| Preoptic Area | 3 | 1998 | 132 | 0.200 |
Why?
|
| Oligopeptides | 2 | 2007 | 1195 | 0.200 |
Why?
|
| Gene Expression Regulation | 17 | 2005 | 11923 | 0.200 |
Why?
|
| Patient Compliance | 1 | 2012 | 2697 | 0.190 |
Why?
|
| Imidazoles | 1 | 2008 | 1169 | 0.190 |
Why?
|
| Phorbols | 4 | 1985 | 44 | 0.190 |
Why?
|
| Receptors, Interleukin-3 | 2 | 1999 | 29 | 0.190 |
Why?
|
| Drug Discovery | 4 | 2014 | 1068 | 0.190 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 980 | 0.190 |
Why?
|
| Drug Resistance | 5 | 2021 | 1592 | 0.190 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 621 | 0.180 |
Why?
|
| S Phase | 5 | 2006 | 424 | 0.180 |
Why?
|
| Models, Molecular | 12 | 2016 | 5388 | 0.180 |
Why?
|
| K562 Cells | 9 | 2011 | 644 | 0.180 |
Why?
|
| Piperidines | 2 | 2020 | 1667 | 0.180 |
Why?
|
| Pyrroles | 2 | 2019 | 1122 | 0.180 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 5 | 1996 | 49 | 0.180 |
Why?
|
| Neutrophils | 11 | 1994 | 3779 | 0.180 |
Why?
|
| Antigens, Neoplasm | 18 | 1991 | 1997 | 0.180 |
Why?
|
| Flow Cytometry | 15 | 2015 | 5891 | 0.180 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2006 | 616 | 0.180 |
Why?
|
| Acute Disease | 14 | 2004 | 7236 | 0.180 |
Why?
|
| Mice, Inbred NOD | 4 | 2017 | 1837 | 0.180 |
Why?
|
| Phosphatidylinositols | 1 | 2001 | 280 | 0.180 |
Why?
|
| Guanine Nucleotide-Releasing Factor 2 | 1 | 1999 | 5 | 0.170 |
Why?
|
| Colony-Forming Units Assay | 12 | 1992 | 351 | 0.170 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 168 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2004 | 2745 | 0.170 |
Why?
|
| Cytoskeleton | 3 | 2003 | 1178 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3828 | 0.170 |
Why?
|
| Paxillin | 9 | 2003 | 86 | 0.170 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 3 | 2005 | 102 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2010 | 2780 | 0.160 |
Why?
|
| Genes, Retinoblastoma | 4 | 1992 | 125 | 0.160 |
Why?
|
| Doxycycline | 4 | 2021 | 348 | 0.160 |
Why?
|
| Oncogene Proteins v-abl | 2 | 2000 | 19 | 0.160 |
Why?
|
| Talin | 2 | 1996 | 47 | 0.160 |
Why?
|
| Protein Binding | 12 | 2005 | 9327 | 0.160 |
Why?
|
| Antigens, CD | 10 | 2002 | 4032 | 0.160 |
Why?
|
| Vanadates | 6 | 2000 | 82 | 0.160 |
Why?
|
| Methylation | 1 | 2022 | 1076 | 0.160 |
Why?
|
| Quinazolines | 1 | 2005 | 1369 | 0.160 |
Why?
|
| NF-kappa B | 3 | 2010 | 2493 | 0.160 |
Why?
|
| Health Resources | 2 | 2019 | 948 | 0.160 |
Why?
|
| Cell Separation | 14 | 2000 | 1717 | 0.160 |
Why?
|
| Medication Adherence | 1 | 2010 | 2191 | 0.160 |
Why?
|
| Ubiquitination | 2 | 2020 | 1008 | 0.150 |
Why?
|
| Oncogene Proteins | 3 | 2002 | 715 | 0.150 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 1986 | 1442 | 0.150 |
Why?
|
| Interleukin-2 | 9 | 1996 | 1894 | 0.150 |
Why?
|
| Half-Life | 3 | 2012 | 648 | 0.150 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2021 | 306 | 0.150 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 420 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 2005 | 1055 | 0.150 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 243 | 0.150 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2018 | 112 | 0.150 |
Why?
|
| Gene Expression Profiling | 5 | 2016 | 9532 | 0.150 |
Why?
|
| Mice, SCID | 4 | 2015 | 2626 | 0.150 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2024 | 1433 | 0.150 |
Why?
|
| Hypothalamus, Anterior | 1 | 1997 | 12 | 0.140 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 380 | 0.140 |
Why?
|
| Streptomyces | 1 | 2017 | 91 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2010 | 3239 | 0.140 |
Why?
|
| Triazines | 1 | 2019 | 311 | 0.140 |
Why?
|
| Sirolimus | 5 | 2005 | 1539 | 0.140 |
Why?
|
| Alleles | 4 | 2019 | 6893 | 0.140 |
Why?
|
| Binding Sites | 10 | 2012 | 6014 | 0.140 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 9 | 1991 | 221 | 0.140 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2021 | 1642 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2004 | 1939 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2002 | 1965 | 0.140 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2016 | 17 | 0.140 |
Why?
|
| Simian virus 40 | 5 | 1980 | 291 | 0.140 |
Why?
|
| Neoplasm Transplantation | 5 | 2016 | 2012 | 0.140 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 1085 | 0.130 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.130 |
Why?
|
| Hematopoietic System | 1 | 1996 | 110 | 0.130 |
Why?
|
| Retroviridae | 7 | 2005 | 846 | 0.130 |
Why?
|
| Cell Communication | 6 | 2013 | 1660 | 0.130 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 2 | 1994 | 21 | 0.130 |
Why?
|
| Gene Expression | 13 | 2015 | 7587 | 0.130 |
Why?
|
| Leukemia, B-Cell | 1 | 2016 | 86 | 0.130 |
Why?
|
| Blood Cells | 3 | 1996 | 309 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2008 | 31 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2007 | 2800 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1074 | 0.120 |
Why?
|
| Ethers, Cyclic | 2 | 1992 | 32 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 1998 | 661 | 0.120 |
Why?
|
| Burkitt Lymphoma | 2 | 2016 | 338 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2014 | 635 | 0.120 |
Why?
|
| Receptors, Colony-Stimulating Factor | 6 | 1990 | 51 | 0.120 |
Why?
|
| Body Temperature Regulation | 1 | 1997 | 292 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 183 | 0.120 |
Why?
|
| Glycogen Synthase | 1 | 2015 | 62 | 0.120 |
Why?
|
| Blotting, Western | 11 | 2010 | 5022 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2009 | 121 | 0.120 |
Why?
|
| Carcinoma, Small Cell | 5 | 2003 | 419 | 0.120 |
Why?
|
| Receptors, Interleukin-2 | 4 | 1989 | 564 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3427 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 8 | 2016 | 6226 | 0.120 |
Why?
|
| Female | 53 | 2021 | 396660 | 0.120 |
Why?
|
| Growth Inhibitors | 4 | 2005 | 375 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1604 | 0.120 |
Why?
|
| Clone Cells | 10 | 1994 | 1669 | 0.120 |
Why?
|
| Glycogen | 1 | 2015 | 252 | 0.120 |
Why?
|
| Receptors, Cytokine | 3 | 2009 | 258 | 0.110 |
Why?
|
| Antigens, Viral | 6 | 1982 | 994 | 0.110 |
Why?
|
| Ligands | 7 | 2009 | 3273 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12790 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 4 | 2016 | 2824 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2013 | 3948 | 0.110 |
Why?
|
| 3T3 Cells | 5 | 2000 | 1081 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-crk | 3 | 1999 | 13 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2005 | 1677 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2006 | 317 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2005 | 4209 | 0.110 |
Why?
|
| Cell Nucleus | 6 | 2010 | 2875 | 0.110 |
Why?
|
| RNA Interference | 1 | 2022 | 2829 | 0.110 |
Why?
|
| Male | 52 | 2021 | 364203 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-vav | 3 | 2002 | 91 | 0.110 |
Why?
|
| Retinoblastoma Protein | 5 | 2021 | 670 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2009 | 1144 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 1992 | 327 | 0.110 |
Why?
|
| Repressor Proteins | 4 | 2007 | 2979 | 0.110 |
Why?
|
| Thiophenes | 1 | 2017 | 570 | 0.110 |
Why?
|
| Time Factors | 20 | 2007 | 40154 | 0.110 |
Why?
|
| Histiocytes | 2 | 1987 | 97 | 0.110 |
Why?
|
| Hydroxamic Acids | 3 | 2004 | 483 | 0.100 |
Why?
|
| Hydrogen Peroxide | 3 | 2002 | 740 | 0.100 |
Why?
|
| Hypereosinophilic Syndrome | 2 | 2003 | 97 | 0.100 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 230 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 7 | 2004 | 1854 | 0.100 |
Why?
|
| Lymphocyte Activation | 11 | 1997 | 5499 | 0.100 |
Why?
|
| Rosette Formation | 9 | 1988 | 152 | 0.100 |
Why?
|
| Middle Aged | 39 | 2021 | 223233 | 0.100 |
Why?
|
| Gamma Rays | 2 | 2007 | 324 | 0.100 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2011 | 25 | 0.100 |
Why?
|
| Preleukemia | 4 | 1986 | 34 | 0.100 |
Why?
|
| Translocation, Genetic | 6 | 2004 | 1391 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-raf | 5 | 1996 | 205 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2011 | 33 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 1889 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2019 | 2428 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 594 | 0.090 |
Why?
|
| Pimozide | 1 | 2011 | 21 | 0.090 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2006 | 176 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2011 | 218 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 526 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2021 | 65295 | 0.090 |
Why?
|
| Adult | 42 | 2021 | 223317 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2010 | 4349 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2001 | 1729 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 8 | 2005 | 2710 | 0.090 |
Why?
|
| Benzylamines | 1 | 2011 | 251 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2011 | 245 | 0.090 |
Why?
|
| Comorbidity | 2 | 2019 | 10582 | 0.090 |
Why?
|
| Drug Approval | 1 | 2017 | 820 | 0.090 |
Why?
|
| Indazoles | 1 | 2012 | 306 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2007 | 1150 | 0.090 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 1947 | 0.090 |
Why?
|
| STAT1 Transcription Factor | 3 | 1996 | 341 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2004 | 678 | 0.090 |
Why?
|
| Adenosine Triphosphate | 2 | 2010 | 2001 | 0.080 |
Why?
|
| Serous Membrane | 1 | 1989 | 22 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2001 | 1465 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2011 | 1337 | 0.080 |
Why?
|
| COS Cells | 2 | 2002 | 1135 | 0.080 |
Why?
|
| Stem Cells | 5 | 1993 | 3535 | 0.080 |
Why?
|
| Pyridones | 2 | 2013 | 819 | 0.080 |
Why?
|
| Superoxides | 3 | 1989 | 388 | 0.080 |
Why?
|
| I-kappa B Proteins | 1 | 2010 | 210 | 0.080 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1892 | 0.080 |
Why?
|
| Lymphocytes | 8 | 1996 | 2605 | 0.080 |
Why?
|
| Threonine | 1 | 2010 | 272 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2015 | 1903 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 2 | 2014 | 945 | 0.080 |
Why?
|
| Chimera | 2 | 2007 | 454 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 1997 | 224 | 0.080 |
Why?
|
| Clinical Trials as Topic | 4 | 2009 | 8048 | 0.080 |
Why?
|
| Prognosis | 11 | 2021 | 29963 | 0.080 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 8535 | 0.080 |
Why?
|
| Survival Rate | 8 | 2015 | 12823 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 1244 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 252 | 0.080 |
Why?
|
| HL-60 Cells | 3 | 2018 | 364 | 0.080 |
Why?
|
| Hydroxyurea | 3 | 2000 | 284 | 0.080 |
Why?
|
| DNA, Neoplasm | 4 | 2004 | 1741 | 0.080 |
Why?
|
| Recurrence | 3 | 2019 | 8504 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 2004 | 4167 | 0.080 |
Why?
|
| Aminoacridines | 2 | 1985 | 9 | 0.080 |
Why?
|
| Viral Proteins | 3 | 2002 | 1801 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2021 | 1982 | 0.080 |
Why?
|
| Biological Factors | 1 | 1989 | 155 | 0.080 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 342 | 0.080 |
Why?
|
| Antigens, CD34 | 3 | 2001 | 655 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 998 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2009 | 390 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2004 | 2176 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 1990 | 305 | 0.070 |
Why?
|
| Disease Management | 1 | 2019 | 2531 | 0.070 |
Why?
|
| Mediastinal Neoplasms | 2 | 1983 | 403 | 0.070 |
Why?
|
| Cyclin D2 | 3 | 2006 | 97 | 0.070 |
Why?
|
| Integrins | 3 | 1997 | 840 | 0.070 |
Why?
|
| Tumor Stem Cell Assay | 6 | 2002 | 116 | 0.070 |
Why?
|
| Killer Cells, Natural | 3 | 1987 | 2209 | 0.070 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2007 | 32 | 0.070 |
Why?
|
| Cycloheximide | 3 | 2000 | 340 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 3 | 1996 | 46 | 0.070 |
Why?
|
| Lymphokines | 4 | 2002 | 924 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2008 | 2061 | 0.070 |
Why?
|
| Retinoblastoma | 1 | 1990 | 321 | 0.070 |
Why?
|
| Aged | 25 | 2021 | 171319 | 0.070 |
Why?
|
| Vinculin | 2 | 1997 | 58 | 0.070 |
Why?
|
| Radiation Chimera | 1 | 2007 | 216 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 4572 | 0.070 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 1228 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1989 | 393 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2721 | 0.070 |
Why?
|
| Leukemia, Promyelocytic, Acute | 3 | 2003 | 249 | 0.070 |
Why?
|
| Immunotoxins | 3 | 1999 | 175 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 1997 | 3702 | 0.070 |
Why?
|
| Genes, bcl-2 | 1 | 2007 | 119 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2013 | 3621 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2007 | 178 | 0.070 |
Why?
|
| Plasmids | 4 | 2003 | 2268 | 0.070 |
Why?
|
| Mice, Inbred C3H | 3 | 1997 | 915 | 0.070 |
Why?
|
| Macromolecular Substances | 5 | 1996 | 1430 | 0.070 |
Why?
|
| Pyridines | 2 | 2012 | 2890 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2021 | 562 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2021 | 81659 | 0.070 |
Why?
|
| Insurance Claim Review | 1 | 2010 | 744 | 0.060 |
Why?
|
| Alprostadil | 1 | 1986 | 86 | 0.060 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2006 | 102 | 0.060 |
Why?
|
| Protein Transport | 2 | 2002 | 1944 | 0.060 |
Why?
|
| Culture Media | 6 | 1989 | 892 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2010 | 837 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2000 | 6067 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 5 | 2010 | 5796 | 0.060 |
Why?
|
| Metabolomics | 1 | 2015 | 1675 | 0.060 |
Why?
|
| RNA, Neoplasm | 5 | 1992 | 748 | 0.060 |
Why?
|
| Leukocyte Count | 7 | 1995 | 1606 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2005 | 108 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 4 | 2002 | 183 | 0.060 |
Why?
|
| Bone Marrow Purging | 3 | 1999 | 108 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2000 | 645 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2004 | 2509 | 0.060 |
Why?
|
| Antibodies, Neoplasm | 2 | 1984 | 282 | 0.060 |
Why?
|
| Acetylation | 2 | 2004 | 1055 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1990 | 1305 | 0.060 |
Why?
|
| Mycoplasma | 1 | 2005 | 146 | 0.060 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 1989 | 186 | 0.060 |
Why?
|
| Epothilones | 1 | 2004 | 42 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 1997 | 546 | 0.060 |
Why?
|
| Cyclin D3 | 2 | 1995 | 54 | 0.060 |
Why?
|
| Interphase | 5 | 1989 | 226 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2007 | 3610 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 476 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2005 | 315 | 0.060 |
Why?
|
| Karyotyping | 9 | 2003 | 1176 | 0.060 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 18330 | 0.060 |
Why?
|
| Blood Cell Count | 2 | 2004 | 404 | 0.060 |
Why?
|
| HLA-DR Antigens | 6 | 1995 | 609 | 0.060 |
Why?
|
| Sequence Deletion | 3 | 1998 | 1494 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 705 | 0.060 |
Why?
|
| Luciferases | 2 | 2003 | 713 | 0.060 |
Why?
|
| DNA Primers | 5 | 2006 | 2827 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 194 | 0.060 |
Why?
|
| Proteomics | 1 | 2017 | 3913 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 4567 | 0.050 |
Why?
|
| DNA Replication | 7 | 1992 | 1426 | 0.050 |
Why?
|
| Chromosome Aberrations | 6 | 1995 | 1776 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6844 | 0.050 |
Why?
|
| Glycoproteins | 2 | 1991 | 2200 | 0.050 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 148 | 0.050 |
Why?
|
| Membrane Potentials | 6 | 1997 | 1085 | 0.050 |
Why?
|
| Mosaicism | 1 | 2007 | 480 | 0.050 |
Why?
|
| Mesothelioma | 1 | 1989 | 774 | 0.050 |
Why?
|
| Artificial Gene Fusion | 1 | 2003 | 56 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2001 | 2887 | 0.050 |
Why?
|
| Thrombocytopenia | 3 | 1990 | 1172 | 0.050 |
Why?
|
| Morpholines | 2 | 2010 | 584 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1168 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2003 | 114 | 0.050 |
Why?
|
| Primary Myelofibrosis | 1 | 2005 | 208 | 0.050 |
Why?
|
| Fever | 3 | 1998 | 1605 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2004 | 4616 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2005 | 607 | 0.050 |
Why?
|
| Peptides | 5 | 2009 | 4348 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 1676 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 697 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 501 | 0.050 |
Why?
|
| Ankyrins | 1 | 2002 | 123 | 0.050 |
Why?
|
| Oncogene Protein v-cbl | 1 | 2002 | 11 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 1999 | 1130 | 0.050 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 2429 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2004 | 1750 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 21178 | 0.050 |
Why?
|
| Hydroquinones | 1 | 2002 | 34 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 1988 | 1352 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 547 | 0.050 |
Why?
|
| Interleukin-6 | 5 | 2004 | 3227 | 0.050 |
Why?
|
| Drug Evaluation | 3 | 1991 | 641 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1562 | 0.050 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 1524 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2006 | 6310 | 0.050 |
Why?
|
| Okadaic Acid | 2 | 1992 | 67 | 0.050 |
Why?
|
| Leupeptins | 1 | 2001 | 113 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 350 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 411 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 414 | 0.050 |
Why?
|
| Growth Cones | 1 | 2002 | 117 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3611 | 0.050 |
Why?
|
| Muscles | 2 | 2006 | 1576 | 0.050 |
Why?
|
| Introns | 1 | 2004 | 965 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 2 | 2002 | 101 | 0.050 |
Why?
|
| Genes, fos | 2 | 1999 | 176 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2002 | 455 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2005 | 1472 | 0.050 |
Why?
|
| Asparagine | 1 | 2001 | 120 | 0.050 |
Why?
|
| Oncogene Fusion | 1 | 2021 | 84 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 10393 | 0.050 |
Why?
|
| Phenotype | 12 | 2016 | 16718 | 0.050 |
Why?
|
| Adamantane | 1 | 2002 | 148 | 0.050 |
Why?
|
| Temperature | 5 | 1997 | 2232 | 0.040 |
Why?
|
| Microscopy, Video | 2 | 2000 | 241 | 0.040 |
Why?
|
| Chromones | 1 | 2000 | 148 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 1992 | 281 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 187 | 0.040 |
Why?
|
| Multigene Family | 2 | 2002 | 1081 | 0.040 |
Why?
|
| Rotenone | 1 | 2000 | 50 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 3 | 1991 | 286 | 0.040 |
Why?
|
| L-Selectin | 5 | 1991 | 212 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2007 | 1019 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2002 | 832 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2010 | 2472 | 0.040 |
Why?
|
| Endothelium, Vascular | 3 | 1991 | 4424 | 0.040 |
Why?
|
| Primates | 1 | 1983 | 519 | 0.040 |
Why?
|
| Crk-Associated Substrate Protein | 2 | 1997 | 39 | 0.040 |
Why?
|
| Retinoblastoma-Like Protein p130 | 2 | 1997 | 72 | 0.040 |
Why?
|
| Phosphotransferases | 2 | 1993 | 302 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 4 | 2004 | 7469 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 882 | 0.040 |
Why?
|
| Cytochalasin D | 2 | 1999 | 91 | 0.040 |
Why?
|
| Species Specificity | 2 | 2000 | 2412 | 0.040 |
Why?
|
| DNA Repair | 1 | 2009 | 2050 | 0.040 |
Why?
|
| Genes, Insect | 1 | 2000 | 265 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2004 | 1626 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 671 | 0.040 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2000 | 37 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2003 | 1526 | 0.040 |
Why?
|
| Thymidine | 3 | 1991 | 297 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2000 | 252 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2668 | 0.040 |
Why?
|
| Phthalazines | 1 | 2002 | 397 | 0.040 |
Why?
|
| Receptors, Interleukin-5 | 1 | 1999 | 20 | 0.040 |
Why?
|
| Thiocarbamates | 1 | 1999 | 30 | 0.040 |
Why?
|
| Mercaptoethanol | 1 | 1999 | 61 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 1999 | 120 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 563 | 0.040 |
Why?
|
| Dexamethasone | 4 | 2004 | 1963 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 1999 | 54 | 0.040 |
Why?
|
| Codon | 1 | 2001 | 599 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 1991 | 1141 | 0.040 |
Why?
|
| Antibody Specificity | 4 | 1997 | 1062 | 0.040 |
Why?
|
| Calcium | 5 | 1989 | 5792 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1999 | 582 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 2 | 1982 | 840 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2000 | 1372 | 0.040 |
Why?
|
| Cell Membrane | 3 | 1987 | 3642 | 0.040 |
Why?
|
| Lipopolysaccharides | 4 | 1998 | 2217 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2000 | 412 | 0.040 |
Why?
|
| Liver | 5 | 2010 | 7578 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1998 | 111 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 1999 | 253 | 0.040 |
Why?
|
| Spodoptera | 2 | 1996 | 140 | 0.040 |
Why?
|
| Hydrogen Bonding | 2 | 2012 | 290 | 0.040 |
Why?
|
| Tolmetin | 1 | 1998 | 24 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 2628 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 2093 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1655 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12536 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2003 | 1384 | 0.040 |
Why?
|
| Leukocytes | 4 | 1991 | 2034 | 0.040 |
Why?
|
| Fibronectins | 2 | 1999 | 722 | 0.040 |
Why?
|
| Macrophages | 8 | 1988 | 5785 | 0.040 |
Why?
|
| Rabbits | 3 | 1995 | 4751 | 0.040 |
Why?
|
| Exons | 1 | 2004 | 2391 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1983 | 498 | 0.040 |
Why?
|
| Bovine papillomavirus 1 | 1 | 1997 | 75 | 0.040 |
Why?
|
| Genes, myc | 3 | 2000 | 391 | 0.040 |
Why?
|
| Erythroblasts | 2 | 1988 | 141 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 1999 | 262 | 0.040 |
Why?
|
| RNA | 3 | 2000 | 2715 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 521 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 1999 | 457 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2002 | 682 | 0.040 |
Why?
|
| Neprilysin | 3 | 1991 | 487 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 4 | 1987 | 341 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 59548 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14476 | 0.040 |
Why?
|
| Son of Sevenless Proteins | 1 | 1997 | 27 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2002 | 1504 | 0.040 |
Why?
|
| Lymphocytosis | 1 | 1978 | 121 | 0.040 |
Why?
|
| Nocodazole | 2 | 1999 | 95 | 0.040 |
Why?
|
| Reticulocytes | 1 | 1978 | 287 | 0.040 |
Why?
|
| Receptors, Thrombopoietin | 2 | 1995 | 159 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 1999 | 339 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 2 | 2002 | 211 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 411 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2003 | 453 | 0.030 |
Why?
|
| Neoplasms | 3 | 2013 | 22350 | 0.030 |
Why?
|
| Epitopes | 6 | 2000 | 2526 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2005 | 872 | 0.030 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 1996 | 87 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 1996 | 174 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3797 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.030 |
Why?
|
| Reference Values | 2 | 1997 | 4918 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 3511 | 0.030 |
Why?
|
| Thymoma | 1 | 1978 | 186 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2004 | 1345 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 1978 | 331 | 0.030 |
Why?
|
| Caspases | 3 | 2005 | 881 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1989 | 2478 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1997 | 405 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1997 | 342 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 361 | 0.030 |
Why?
|
| Methotrexate | 2 | 1997 | 1718 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4280 | 0.030 |
Why?
|
| Eye Diseases | 1 | 1981 | 660 | 0.030 |
Why?
|
| Mammals | 1 | 2001 | 1135 | 0.030 |
Why?
|
| Disease Progression | 1 | 2013 | 13646 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 1995 | 1995 | 0.030 |
Why?
|
| Neutropenia | 3 | 1990 | 892 | 0.030 |
Why?
|
| Bone Marrow Examination | 2 | 1988 | 154 | 0.030 |
Why?
|
| TYK2 Kinase | 1 | 1995 | 38 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.030 |
Why?
|
| Protamine Kinase | 1 | 1995 | 12 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1996 | 313 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 4026 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20169 | 0.030 |
Why?
|
| Immunologic Techniques | 2 | 1992 | 213 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1995 | 147 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 1995 | 108 | 0.030 |
Why?
|
| Zebrafish | 1 | 2007 | 3036 | 0.030 |
Why?
|
| Chromosome Disorders | 3 | 1995 | 498 | 0.030 |
Why?
|
| Endotoxins | 2 | 1988 | 519 | 0.030 |
Why?
|
| Lung Neoplasms | 5 | 2003 | 13491 | 0.030 |
Why?
|
| DNA | 7 | 1990 | 7210 | 0.030 |
Why?
|
| Immunocompetence | 1 | 1995 | 138 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2010 | 8068 | 0.030 |
Why?
|
| Ouabain | 2 | 1988 | 246 | 0.030 |
Why?
|
| Ricin | 2 | 1992 | 70 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1995 | 115 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1998 | 370 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1994 | 5 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1994 | 524 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2002 | 1811 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 1991 | 2227 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 2 | 1985 | 64 | 0.030 |
Why?
|
| Rats | 6 | 2003 | 23713 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1994 | 71 | 0.030 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1991 | 53 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1994 | 169 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 534 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2003 | 3402 | 0.030 |
Why?
|
| Cell Transformation, Viral | 3 | 1980 | 527 | 0.030 |
Why?
|
| Mitosis | 2 | 2005 | 1176 | 0.030 |
Why?
|
| Dog Diseases | 1 | 1994 | 143 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2001 | 957 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 711 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1996 | 597 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1994 | 130 | 0.030 |
Why?
|
| Gene Rearrangement | 3 | 2003 | 1141 | 0.030 |
Why?
|
| Busulfan | 2 | 1986 | 259 | 0.030 |
Why?
|
| Drug Administration Schedule | 3 | 1991 | 4855 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1997 | 857 | 0.030 |
Why?
|
| Drosophila | 1 | 2000 | 1509 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1997 | 909 | 0.030 |
Why?
|
| Actins | 2 | 1997 | 2059 | 0.030 |
Why?
|
| Glycolysis | 2 | 2015 | 836 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2001 | 2765 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 2 | 1995 | 467 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2013 | 136 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9551 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 899 | 0.030 |
Why?
|
| Deferoxamine | 1 | 1993 | 155 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 842 | 0.030 |
Why?
|
| Research | 1 | 2001 | 1977 | 0.030 |
Why?
|
| Receptors, Transferrin | 3 | 1992 | 300 | 0.030 |
Why?
|
| Melphalan | 1 | 1994 | 421 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1992 | 365 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2001 | 1089 | 0.020 |
Why?
|
| Complement System Proteins | 4 | 1992 | 738 | 0.020 |
Why?
|
| Isoantigens | 1 | 1994 | 562 | 0.020 |
Why?
|
| Erythropoiesis | 2 | 1987 | 691 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2005 | 730 | 0.020 |
Why?
|
| Graft Rejection | 2 | 1996 | 4498 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 297 | 0.020 |
Why?
|
| Potassium | 5 | 1989 | 1314 | 0.020 |
Why?
|
| Remission Induction | 4 | 2003 | 2408 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 205 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1993 | 478 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1991 | 661 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Mannosephosphates | 1 | 1991 | 11 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1996 | 707 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 3 | 1990 | 960 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1836 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.020 |
Why?
|
| Antioxidants | 1 | 1999 | 1671 | 0.020 |
Why?
|
| Mannans | 1 | 1991 | 58 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 775 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1991 | 282 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1995 | 386 | 0.020 |
Why?
|
| Transplantation, Autologous | 3 | 1994 | 2118 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1990 | 113 | 0.020 |
Why?
|
| Phosphoserine | 1 | 1991 | 204 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 1991 | 689 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 110 | 0.020 |
Why?
|
| Methods | 2 | 1988 | 1065 | 0.020 |
Why?
|
| Iodine Radioisotopes | 2 | 1991 | 1029 | 0.020 |
Why?
|
| Substance P | 1 | 1991 | 331 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1990 | 82 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11097 | 0.020 |
Why?
|
| Molecular Weight | 4 | 1982 | 2168 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1989 | 38 | 0.020 |
Why?
|
| Cytosol | 3 | 1988 | 885 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 14098 | 0.020 |
Why?
|
| Immunophenotyping | 3 | 2003 | 1864 | 0.020 |
Why?
|
| Receptors, Complement | 2 | 1989 | 254 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1986 | 164 | 0.020 |
Why?
|
| NADP | 1 | 2010 | 229 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 294 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 1733 | 0.020 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1989 | 94 | 0.020 |
Why?
|
| Action Potentials | 1 | 1997 | 1835 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5141 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1989 | 135 | 0.020 |
Why?
|
| Neomycin | 1 | 1989 | 94 | 0.020 |
Why?
|
| Antibodies | 2 | 1994 | 2419 | 0.020 |
Why?
|
| Glucose | 2 | 2011 | 4341 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2004 | 451 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 22361 | 0.020 |
Why?
|
| Peroxidase | 2 | 1989 | 610 | 0.020 |
Why?
|
| Amsacrine | 2 | 1985 | 19 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 781 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1972 | 930 | 0.020 |
Why?
|
| Microinjections | 3 | 1998 | 319 | 0.020 |
Why?
|
| Muscle Contraction | 2 | 1972 | 1208 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 16036 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1347 | 0.020 |
Why?
|
| Infusions, Parenteral | 2 | 1985 | 395 | 0.020 |
Why?
|
| Erythrocytes | 4 | 1989 | 2411 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 1988 | 157 | 0.020 |
Why?
|
| Lactones | 1 | 1990 | 315 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
| Leukopenia | 1 | 1988 | 212 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3944 | 0.020 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2008 | 53 | 0.020 |
Why?
|
| Thromboplastin | 1 | 1989 | 289 | 0.020 |
Why?
|
| Arabinofuranosylcytosine Triphosphate | 1 | 1987 | 7 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 1988 | 197 | 0.020 |
Why?
|
| Arabinofuranosyluracil | 1 | 1987 | 10 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 41718 | 0.020 |
Why?
|
| Replicon | 1 | 1987 | 35 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
| Macrophage Activation | 2 | 1988 | 554 | 0.020 |
Why?
|
| Collodion | 1 | 1987 | 33 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1991 | 792 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 351 | 0.020 |
Why?
|
| Sarcoma | 2 | 1989 | 1802 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2000 | 4560 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 1989 | 371 | 0.020 |
Why?
|
| Cell Count | 3 | 1987 | 1825 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1987 | 154 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1987 | 176 | 0.020 |
Why?
|
| Sodium | 3 | 1987 | 1594 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1994 | 975 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1987 | 105 | 0.020 |
Why?
|
| Anemia, Refractory | 1 | 1986 | 17 | 0.020 |
Why?
|
| Carbocyanines | 1 | 1987 | 177 | 0.020 |
Why?
|
| Purines | 1 | 2010 | 614 | 0.020 |
Why?
|
| Cell Death | 1 | 1992 | 1677 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 2002 | 11063 | 0.020 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2005 | 5 | 0.020 |
Why?
|
| Callitrichinae | 1 | 1985 | 20 | 0.020 |
Why?
|
| Saguinus | 1 | 1985 | 12 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 59980 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 980 | 0.020 |
Why?
|
| Suspensions | 1 | 1986 | 68 | 0.020 |
Why?
|
| Eflornithine | 1 | 1985 | 31 | 0.020 |
Why?
|
| Pregnancy | 2 | 2007 | 30238 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 946 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 1991 | 897 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1890 | 0.020 |
Why?
|
| Ornithine | 1 | 1985 | 79 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1996 | 1502 | 0.020 |
Why?
|
| Agar | 1 | 1985 | 51 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 940 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 1989 | 537 | 0.020 |
Why?
|
| Endocytosis | 1 | 1990 | 951 | 0.020 |
Why?
|
| Polyglutamic Acid | 1 | 1985 | 46 | 0.020 |
Why?
|
| Tritium | 1 | 1985 | 707 | 0.020 |
Why?
|
| Cricetinae | 2 | 2002 | 2415 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1985 | 238 | 0.020 |
Why?
|
| Phloretin | 1 | 2004 | 16 | 0.020 |
Why?
|
| Adolescent | 11 | 2006 | 89046 | 0.020 |
Why?
|
| Phagocytes | 1 | 1986 | 292 | 0.010 |
Why?
|
| Epithelium | 1 | 1989 | 1606 | 0.010 |
Why?
|
| Splenectomy | 1 | 1986 | 390 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1211 | 0.010 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1984 | 32 | 0.010 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 93 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2011 | 2658 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2004 | 194 | 0.010 |
Why?
|
| Chromosomes, Human, 1-3 | 1 | 1983 | 21 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2004 | 192 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1983 | 69 | 0.010 |
Why?
|
| ras Proteins | 1 | 2009 | 1054 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2004 | 322 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 2004 | 170 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 1986 | 231 | 0.010 |
Why?
|
| Cytogenetics | 2 | 1995 | 198 | 0.010 |
Why?
|
| Biological Assay | 1 | 1987 | 626 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 2006 | 2221 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3114 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3804 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1751 | 0.010 |
Why?
|
| Mesonephroma | 1 | 1983 | 21 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2000 | 5389 | 0.010 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1983 | 45 | 0.010 |
Why?
|
| Dysgerminoma | 1 | 1983 | 66 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 2006 | 393 | 0.010 |
Why?
|
| Collagen | 1 | 1992 | 2636 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 634 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1989 | 998 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2004 | 255 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2004 | 259 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1996 | 4405 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1996 | 492 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1990 | 1791 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1982 | 153 | 0.010 |
Why?
|
| HeLa Cells | 2 | 2001 | 3073 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 740 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22254 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 437 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 102 | 0.010 |
Why?
|
| Tachycardia | 1 | 1985 | 598 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 1983 | 121 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 1991 | 318 | 0.010 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2003 | 112 | 0.010 |
Why?
|
| Goats | 1 | 1982 | 166 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 435 | 0.010 |
Why?
|
| Armadillo Domain Proteins | 1 | 2002 | 25 | 0.010 |
Why?
|
| Interferon Type I | 1 | 1986 | 568 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 577 | 0.010 |
Why?
|
| Catenins | 1 | 2002 | 44 | 0.010 |
Why?
|
| Mitobronitol | 1 | 1981 | 3 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2002 | 118 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 2002 | 88 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2003 | 377 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 109 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2003 | 42606 | 0.010 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 61 | 0.010 |
Why?
|
| Syndrome | 2 | 1985 | 3271 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2002 | 317 | 0.010 |
Why?
|
| Vinca Alkaloids | 1 | 1981 | 36 | 0.010 |
Why?
|
| Palatine Tonsil | 2 | 1997 | 193 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1981 | 99 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 184 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 324 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2002 | 315 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2002 | 173 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 428 | 0.010 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 308 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1981 | 151 | 0.010 |
Why?
|
| Cells, Immobilized | 1 | 2000 | 35 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 526 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.010 |
Why?
|
| Fetus | 3 | 2002 | 1878 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 899 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 542 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Vincristine | 1 | 1983 | 1040 | 0.010 |
Why?
|
| Spleen | 2 | 2003 | 2292 | 0.010 |
Why?
|
| Serpins | 1 | 2002 | 246 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1774 | 0.010 |
Why?
|
| Teratoma | 1 | 1983 | 405 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6210 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2003 | 308 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 855 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 839 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 663 | 0.010 |
Why?
|
| Aphidicolin | 2 | 1992 | 37 | 0.010 |
Why?
|
| Chick Embryo | 2 | 2000 | 973 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 828 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1985 | 2551 | 0.010 |
Why?
|
| Sheep | 1 | 1982 | 1449 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2010 | 4167 | 0.010 |
Why?
|
| Platelet Count | 2 | 1995 | 784 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 250 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 1376 | 0.010 |
Why?
|
| Hypotension | 1 | 1985 | 888 | 0.010 |
Why?
|
| Trisomy | 2 | 1995 | 260 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1995 | 4745 | 0.010 |
Why?
|
| Eosinophils | 1 | 1984 | 951 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 661 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 559 | 0.010 |
Why?
|
| Infant | 3 | 1994 | 36485 | 0.010 |
Why?
|
| Child | 5 | 2009 | 80771 | 0.010 |
Why?
|
| Solubility | 1 | 2000 | 1078 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1985 | 2350 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2000 | 563 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2003 | 665 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1987 | 1928 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1716 | 0.010 |
Why?
|
| Chromatography | 1 | 1978 | 189 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6260 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1985 | 1801 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2003 | 488 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1998 | 185 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 627 | 0.010 |
Why?
|
| Immunoglobulin M | 2 | 1986 | 1527 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2003 | 699 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2794 | 0.010 |
Why?
|
| Prednisone | 1 | 1983 | 1566 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3139 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2003 | 862 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1997 | 43 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 565 | 0.010 |
Why?
|
| Menorrhagia | 1 | 1978 | 59 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 376 | 0.010 |
Why?
|
| Receptors, Formyl Peptide | 2 | 1988 | 146 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 1474 | 0.010 |
Why?
|
| Neurons | 1 | 1997 | 9517 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1997 | 133 | 0.010 |
Why?
|
| Ketorolac | 1 | 1998 | 95 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2000 | 553 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2063 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1983 | 1075 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2469 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1998 | 398 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 1999 | 896 | 0.010 |
Why?
|
| Mediastinum | 1 | 1978 | 272 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 1996 | 37 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 1319 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2000 | 901 | 0.010 |
Why?
|
| Dogs | 2 | 1994 | 3834 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1986 | 1399 | 0.010 |
Why?
|
| Hematuria | 1 | 1978 | 232 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1981 | 1652 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1996 | 141 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 1996 | 119 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 8108 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1969 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 1 | 1997 | 231 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1987 | 347 | 0.010 |
Why?
|
| HLA-DR7 Antigen | 1 | 1994 | 27 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 27163 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1996 | 330 | 0.010 |
Why?
|
| Estrogens | 1 | 1981 | 1536 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1978 | 992 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1978 | 350 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1994 | 283 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1995 | 310 | 0.010 |
Why?
|
| Moths | 1 | 1994 | 82 | 0.010 |
Why?
|
| HLA Antigens | 3 | 1987 | 1334 | 0.010 |
Why?
|
| Regeneration | 1 | 1983 | 1523 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1996 | 692 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2003 | 2163 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1995 | 432 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 1722 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3445 | 0.010 |
Why?
|
| Periodicity | 1 | 1994 | 347 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1983 | 2257 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 1972 | 50 | 0.010 |
Why?
|
| United States | 1 | 2001 | 72971 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 10092 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1981 | 1883 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1993 | 162 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 56 | 0.010 |
Why?
|
| Bradykinin | 1 | 1972 | 205 | 0.010 |
Why?
|
| Atropine | 1 | 1972 | 243 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1986 | 3114 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 1972 | 93 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 3813 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1992 | 286 | 0.010 |
Why?
|
| Xanthines | 1 | 1972 | 121 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1992 | 167 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1992 | 259 | 0.010 |
Why?
|
| Genistein | 1 | 1991 | 87 | 0.010 |
Why?
|
| Microbial Collagenase | 1 | 1992 | 112 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1978 | 2201 | 0.010 |
Why?
|
| Digoxin | 1 | 1972 | 246 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 111 | 0.010 |
Why?
|
| Isoflavones | 1 | 1991 | 139 | 0.010 |
Why?
|
| Bryostatins | 1 | 1990 | 24 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1972 | 1309 | 0.010 |
Why?
|
| Histamine | 1 | 1972 | 496 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1991 | 119 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1991 | 277 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 13035 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1972 | 628 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1991 | 2568 | 0.010 |
Why?
|
| Ileum | 1 | 1972 | 558 | 0.010 |
Why?
|
| Prostatectomy | 1 | 1978 | 1786 | 0.010 |
Why?
|
| Valinomycin | 1 | 1989 | 17 | 0.010 |
Why?
|
| Naphthol AS D Esterase | 1 | 1989 | 14 | 0.010 |
Why?
|
| Magnetics | 1 | 1992 | 586 | 0.010 |
Why?
|
| Ionomycin | 1 | 1989 | 109 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1983 | 6409 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1989 | 34 | 0.010 |
Why?
|
| E-Selectin | 1 | 1991 | 576 | 0.010 |
Why?
|
| Microspheres | 1 | 1992 | 774 | 0.010 |
Why?
|
| Macrolides | 1 | 1990 | 204 | 0.010 |
Why?
|
| Metaphase | 1 | 1989 | 143 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2004 | 6611 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1989 | 160 | 0.010 |
Why?
|
| Ethers | 1 | 1989 | 72 | 0.010 |
Why?
|
| P-Selectin | 1 | 1991 | 598 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 2678 | 0.000 |
Why?
|
| Amiloride | 1 | 1988 | 116 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 4401 | 0.000 |
Why?
|
| Polycarboxylate Cement | 1 | 1988 | 17 | 0.000 |
Why?
|
| Propionates | 1 | 1989 | 180 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1991 | 647 | 0.000 |
Why?
|
| Antigens, CD19 | 1 | 1991 | 443 | 0.000 |
Why?
|
| Immune Sera | 1 | 1988 | 605 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1989 | 697 | 0.000 |
Why?
|
| Phospholipases | 1 | 1987 | 75 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1972 | 1419 | 0.000 |
Why?
|
| Filtration | 1 | 1988 | 227 | 0.000 |
Why?
|
| Serotonin | 1 | 1972 | 1045 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1057 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1999 | 3464 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1987 | 296 | 0.000 |
Why?
|
| Drug Contamination | 1 | 1988 | 151 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1988 | 11513 | 0.000 |
Why?
|
| Receptors, Complement 3b | 1 | 1986 | 135 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1987 | 241 | 0.000 |
Why?
|
| Chemistry, Physical | 1 | 1986 | 153 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1989 | 1697 | 0.000 |
Why?
|
| Arachidonic Acid | 1 | 1987 | 430 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 486 | 0.000 |
Why?
|
| Haptens | 1 | 1985 | 163 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1989 | 563 | 0.000 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1987 | 766 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1996 | 3078 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1986 | 339 | 0.000 |
Why?
|
| Prospective Studies | 2 | 1987 | 54886 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1989 | 1076 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1985 | 361 | 0.000 |
Why?
|
| Intracellular Fluid | 1 | 1985 | 201 | 0.000 |
Why?
|
| Diterpenes | 1 | 1985 | 169 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1985 | 479 | 0.000 |
Why?
|
| Inosine | 1 | 1985 | 129 | 0.000 |
Why?
|
| Chromosome Banding | 1 | 1984 | 261 | 0.000 |
Why?
|
| Twins | 1 | 1985 | 341 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1985 | 717 | 0.000 |
Why?
|
| Hybridomas | 1 | 1985 | 442 | 0.000 |
Why?
|
| Phospholipids | 1 | 1987 | 778 | 0.000 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1985 | 381 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1985 | 512 | 0.000 |
Why?
|
| Interleukin-4 | 1 | 1987 | 1156 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1998 | 6597 | 0.000 |
Why?
|
| beta 2-Microglobulin | 1 | 1983 | 330 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1985 | 610 | 0.000 |
Why?
|
| Body Temperature | 1 | 1985 | 780 | 0.000 |
Why?
|
| Coronary Circulation | 1 | 1988 | 1603 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1983 | 446 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1984 | 574 | 0.000 |
Why?
|
| Gold | 1 | 1985 | 482 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1983 | 1623 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1987 | 1079 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1986 | 1526 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1985 | 1264 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1980 | 654 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1985 | 1531 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1988 | 4186 | 0.000 |
Why?
|
| Mitochondria | 1 | 1988 | 3678 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1985 | 3468 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1992 | 9410 | 0.000 |
Why?
|
| Virus Replication | 1 | 1982 | 2457 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 39317 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1988 | 5914 | 0.000 |
Why?
|
| Aminophylline | 1 | 1972 | 41 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1972 | 110 | 0.000 |
Why?
|
| Theophylline | 1 | 1972 | 133 | 0.000 |
Why?
|
| Skin | 1 | 1985 | 4499 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1972 | 529 | 0.000 |
Why?
|